Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
editorial
. 1977 Nov 5;117(9):994–996.

Serum digoxin test in perspective.

A Dodek
PMCID: PMC1880205  PMID: 912635

Full text

PDF
994

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLISS H. A., FISHMAN W. E., SMITH P. M. Effect of alterations of blood pH on digitalis toxicity. J Lab Clin Med. 1963 Jul;62:53–58. [PubMed] [Google Scholar]
  2. Beller G. A., Hood W. B., Jr, Smith T. W., Abelmann W. H., Wacker W. E. Correlation of serum magnesium levels and cardiac digitalis intoxication. Am J Cardiol. 1974 Feb;33(2):225–229. doi: 10.1016/0002-9149(74)90279-3. [DOI] [PubMed] [Google Scholar]
  3. Brown D. D., Juhl R. P. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. N Engl J Med. 1976 Nov 4;295(19):1034–1037. doi: 10.1056/NEJM197611042951902. [DOI] [PubMed] [Google Scholar]
  4. Doherty J. E., Perkins W. H. Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease. Ann Intern Med. 1966 Mar;64(3):489–507. doi: 10.7326/0003-4819-64-3-489. [DOI] [PubMed] [Google Scholar]
  5. Edmonds T. T., Howard P. L., Trainer T. D. Measurement of digitoxin and digoxin. N Engl J Med. 1972 Jun 8;286(23):1266–1266. doi: 10.1056/nejm197206082862316. [DOI] [PubMed] [Google Scholar]
  6. Goldman S., Probst P., Selzer A., Cohn K. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am J Cardiol. 1975 May;35(5):651–655. doi: 10.1016/0002-9149(75)90051-x. [DOI] [PubMed] [Google Scholar]
  7. Hayes C. J., Butler V. P., Jr, Gersony W. M. Serum digoxin studies in infants and children. Pediatrics. 1973 Oct;52(4):561–568. [PubMed] [Google Scholar]
  8. Ingelfinger J. A., Goldman P. The serum digitalis concentration--does it diagnose digitalis toxicity? N Engl J Med. 1976 Apr 15;294(16):867–870. doi: 10.1056/NEJM197604152941603. [DOI] [PubMed] [Google Scholar]
  9. Koch-Weser J., Duhme D. W., Greenblatt D. J. Influence of serum digoxin concentration measurements on frequency of digitoxicity. Clin Pharmacol Ther. 1974 Jul;16(1):284–287. doi: 10.1002/cpt1974161part2284. [DOI] [PubMed] [Google Scholar]
  10. Lindenbaum J., Mellow M. H., Blackstone M. O., Butler V. P., Jr Variation in biologic availability of digoxin from four preparations. N Engl J Med. 1971 Dec 9;285(24):1344–1347. doi: 10.1056/NEJM197112092852403. [DOI] [PubMed] [Google Scholar]
  11. Marcus F. I. Current concepts of digoxin therapy. Mod Concepts Cardiovasc Dis. 1976 Feb;45(2):77–84. [PubMed] [Google Scholar]
  12. Marcus F. I. Digitalis pharmacokinetics and metabolism. Am J Med. 1975 Apr;58(4):452–459. doi: 10.1016/0002-9343(75)90116-3. [DOI] [PubMed] [Google Scholar]
  13. Morrison J., Killip T. Serum digitalis and arrhythmia in patients undergoing cardiopulmonary bypass. Circulation. 1973 Feb;47(2):341–352. doi: 10.1161/01.cir.47.2.341. [DOI] [PubMed] [Google Scholar]
  14. Ogilvie R. I., Ruedy J. An educational program in digitalis therapy. JAMA. 1972 Oct 2;222(1):50–55. [PubMed] [Google Scholar]
  15. Smith T. W. Digitalis toxicity: epidemiology and clinical use of serum concentration measurements. Am J Med. 1975 Apr;58(4):470–476. doi: 10.1016/0002-9343(75)90118-7. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES